IP Verse

Perfusion Bioreactor And Related Methods Of Use - EP3697887B1

PatentPatent Analysis

EP3697887

REGENERON PHARMACEUTICALS
Application Number
EP18797333A
Filing Date
Oct 15, 2018
Status
Revoked
Sep 6, 2024
Grant Date
Apr 6, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4252857B1
EP3506931B1
EP3889181B1

Bibliography

The patent EP3697887B1 was granted to Regeneron Pharmaceuticals on Apr 6, 2022 following the initial filing on Oct 15, 2018 under the application number EP18797333A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBJan 9, 2023ADMISSIBLE
SARTORIUS STEDIM BIOTECHDec 21, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents